Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

SUBSEQUENT EVENTS (Narrative) (Details)

v3.21.1
SUBSEQUENT EVENTS (Narrative) (Details) - Subsequent Event [Member]
$ in Thousands
 1 Months Ended 3 Months Ended
Mar. 31, 2021
shares
Mar. 18, 2021
$ / shares
shares
Mar. 30, 2021
USD ($)
Mar. 29, 2021
Acquisition of Trichome Financial Corp. ("Trichome") | Trichome Securityholders [Member]        
Disclosure of non-adjusting events after reporting period [line items]        
Ordinary shares issued for each Trichome Share and convertible instrument held   0.24525    
Number of shares issued   10,104,901    
Par value per share | $ / shares   $ 9.8    
Percentage of voting equity interests acquired   20.06%    
Acquisition of Trichome Financial Corp. ("Trichome") | Financial advisors [Member]        
Disclosure of non-adjusting events after reporting period [line items]        
Number of shares issued   100,916    
Par value per share | $ / shares   $ 9.8    
Supply agreement [Member] | MediPharm Labs Corp. ("MediPharm Labs") [Member] | Adjupharm GmbH ("Adjupharm") [Member]        
Disclosure of non-adjusting events after reporting period [line items]        
Initial term of agreement       2 years
Automatic extension period of agreement       2 years
Base shelf prospectus [Member]        
Disclosure of non-adjusting events after reporting period [line items]        
Threshold limit of offering price of securities | $     $ 250,000  
Arrangement agreement [Member] | MYM Nutraceuticals [Member]        
Disclosure of non-adjusting events after reporting period [line items]        
Ordinary shares issued to shareholders for each common share of MYM 0.022